We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$104B
AUM Growth
+$8.72B
Cap. Flow
-$256M
Cap. Flow %
-0.25%
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
72

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$35.4M
2
P
Everpure Inc
P
+$21M
3
NVDA icon
NVIDIA
NVDA
+$20.7M
4
AMH icon
American Homes 4 Rent
AMH
+$19.3M
5
DAY
Dayforce
DAY
+$19M

Sector Composition

Rank Sector Weight
1 Technology 28.42%
2 Financials 13.09%
3 Healthcare 11.94%
4 Consumer Discretionary 10.95%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TJX icon
76
TJX Companies
TJX
$176B
$239M 0.23%
2,355,109
+12,327
+0.5% +$1.2M
SYK icon
77
Stryker
SYK
$129B
$238M 0.23%
666,096
-1,932
-0.3% -$650K
MS icon
78
Morgan Stanley
MS
$344B
$236M 0.23%
2,511,141
-23,881
-0.9% -$2.1M
CI icon
79
Cigna
CI
$71.8B
$235M 0.23%
645,709
+16,311
+3% +$5.37M
C icon
80
Citigroup
C
$232B
$233M 0.22%
3,682,431
-6,369
-0.2% -$354K
MDT icon
81
Medtronic
MDT
$109B
$230M 0.22%
2,638,209
-20,887
-0.8% -$1.78M
DE icon
82
Deere & Co
DE
$166B
$225M 0.22%
548,551
-18,121
-3% -$6.95M
NKE icon
83
Nike
NKE
$62B
$224M 0.22%
2,384,258
+9,776
+0.4% +$994K
CVS icon
84
CVS Health
CVS
$127B
$218M 0.21%
2,736,224
+14,203
+0.5% +$1.08M
AMT icon
85
American Tower
AMT
$77.9B
$216M 0.21%
1,092,503
-2,041
-0.2% -$407K
ADP icon
86
Automatic Data Processing
ADP
$107B
$213M 0.2%
853,677
+7,261
+0.9% +$1.77M
MRSH
87
Marsh
MRSH
$91.2B
$213M 0.2%
1,033,922
-1,359
-0.1% -$271K
IWB icon
88
iShares Russell 1000 ETF
IWB
$49.9B
$213M 0.2%
739,207
-5,917
-0.8% -$1.62M
SCHW
89
Charles Schwab
SCHW
$188B
$212M 0.2%
2,930,047
-90,924
-3% -$5.99M
SBUX icon
90
Starbucks
SBUX
$121B
$210M 0.2%
2,299,536
+6,914
+0.3% +$643K
UPS icon
91
United Parcel Service
UPS
$91.5B
$206M 0.2%
1,387,244
+10,189
+0.7% +$1.55M
BMY icon
92
Bristol-Myers Squibb
BMY
$130B
$205M 0.2%
3,773,299
+1,609
+0% +$82K
BSX icon
93
Boston Scientific
BSX
$68.8B
$203M 0.2%
2,970,888
+14,602
+0.5% +$939K
MDLZ icon
94
Mondelez International
MDLZ
$79.4B
$202M 0.19%
2,889,822
+18,237
+0.6% +$1.33M
BA icon
95
Boeing
BA
$189B
$197M 0.19%
1,018,691
+15,933
+2% +$3.27M
VRTX icon
96
Vertex Pharmaceuticals
VRTX
$122B
$194M 0.19%
463,227
+4,739
+1% +$2M
ADI icon
97
Analog Devices
ADI
$184B
$193M 0.19%
973,912
-1,162
-0.1% -$223K
LMT icon
98
Lockheed Martin
LMT
$134B
$190M 0.18%
418,421
+8,894
+2% +$3.9M
ZTS icon
99
Zoetis
ZTS
$31.1B
$188M 0.18%
1,110,255
+72,093
+7% +$13.5M
CB icon
100
Chubb
CB
$135B
$188M 0.18%
724,242
+2,458
+0.3% +$604K

Similar funds

RhumbLine Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3.1%. RhumbLine Advisers opened 62 new positions and exited 72, leaving the 4,372-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
  • RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
  • RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
  • RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
  • RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
  • RhumbLine Advisers opened 62 new positions and closed 72 in Q1 2024.
  • RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.

Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.